An expansion of BioPorto Diagnostics Metabolic Marker Portfolio

New Antibodies for Obesity and Diabetes Research

December 2017

BioPorto Diagnostics is happy to now offer antibodies towards human gastric inhibitory polypeptide (hGIP)

The addition of these unique antibodies to the portfolio enable customers working within the area of Obesity and Diabetes to now measure the gut hormone GIP in both the GIP(1-42) and GIP(3-42) versions.

 

 

We are pleased to add the following antibodies to our portfolio and webshop:

Anti-Gastric Inhibitory Peptide (3-42) (GIP (3-42)) Mouse monoclonal antibody

Cat.No. ABS 057-25

 

Anti-Gastric Inhibitory Peptide (3-42)(GIP (3-42)) Mouse monoclonal antibody

Cat.No. ABS 054-14

 

Anti-Gastric Inhibitory Peptide (3-42)(GIP (3-42)) Mouse monoclonal antibody, biotinylated

Cat.No. ABS 054-14B

 

Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody

Cat.No. ABS 054-24

 

Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody

Cat.No. ABS 054-26

 

Anti-Gastric Inhibitory Peptide (GIP) Mouse monoclonal antibody, biotinylated

Cat.No. ABS 054-24B

 

 

Human gastric inhibitory polypeptide (GIP) is a 42 amino acid peptide belonging to the glucagon-secretin family of peptide hormones. It is secreted by endocrine cells in the duodenal mucosa and stimulates glucose-dependent insulin secretion as well as GLP-1 release from more distal endocrine (L) cells in the intestinal mucosa. GIP shows amino-acid sequence similarities to glucagon, GLP-1 and GLP-2 (from approximately 50% identity for glucagon to 30% identity for GLP-2).
 

Find out more about the new antibodies.